Related Experiment Videos

Identification of v-Rel oncogene-induced inhibitor of apoptosis by differential display

M You1, H R Bose

  • 1Department of Microbiology and the Institute for Cellular and Molecular Biology, University of Texas at Austin, 78712-1095, USA.

Insights

The v-Rel oncoprotein activates oncogenic transformation and inhibits apoptosis. Researchers identified ch-IAP1, a novel inhibitor-of-apoptosis protein, which is highly expressed in v-Rel transformed cells and suppresses apoptosis.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • The v-Rel oncoprotein, a member of the Rel/NF-kappaB transcription factor family, is known to induce oncogenic transformation and inhibit apoptosis.
  • Identifying cellular genes aberrantly expressed in v-Rel transformed cells is crucial for understanding oncogenesis.

Purpose of the Study:

  • To identify and characterize novel cellular genes differentially expressed in v-Rel transformed cells.
  • To investigate the role of the identified chicken inhibitor-of-apoptosis protein 1 (ch-IAP1) in apoptosis regulation.

Main Methods:

  • Differential display of mRNA was used to compare gene expression patterns between normal and v-Rel transformed cells.
  • Northern blotting confirmed the differential expression of 10 transcripts, including ch-IAP1.
  • Functional assays were performed to assess the effect of ch-IAP1 on apoptosis.

Main Results:

  • A novel gene, ch-IAP1, encoding a chicken homolog of the inhibitor-of-apoptosis protein (IAP) family, was identified.
  • ch-IAP1 exhibits high expression in v-Rel transformed cells and contains characteristic IAP domains (BIRs and a RING finger).
  • Overexpression of ch-IAP1 suppressed apoptosis induced by caspase-1 (ICE) in mammalian cells and in temperature-sensitive v-Rel transformed cells.

Conclusions:

  • ch-IAP1 is a novel inhibitor-of-apoptosis protein upregulated by v-Rel oncoprotein.
  • ch-IAP1 plays a significant role in inhibiting apoptosis, contributing to v-Rel-mediated oncogenic transformation.
  • ch-IAP1 represents a potential therapeutic target for cancers driven by v-Rel or related pathways.

Related Concept Videos